Sunesis Pharmaceuticals (SNSS)
Add to Watchlists Create an Alert
5.52
+0.02 +0.36%
NASDAQ
May 23, 4:59PM
BATS Real time
Currency in USD
Sunesis Pharmaceuticals Cash from Financing Quarterly:
-0.653M for March 31, 2013Sunesis Pharmaceuticals Historical Cash from Financing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -0.653M |
| Dec. 31, 2012 | 3.766M |
| Sept. 30, 2012 | 33.42M |
| June 30, 2012 | 0.429M |
| March 31, 2012 | 0.032M |
| Dec. 31, 2011 | 9.689M |
| Sept. 30, 2011 | 0.00 |
| June 30, 2011 | 1.966M |
| March 31, 2011 | 2.091M |
| Dec. 31, 2010 | 16.96M |
| Sept. 30, 2010 | -1.501M |
| June 30, 2010 | 38.80M |
| March 31, 2010 | 14.16M |
| Dec. 31, 2009 | 4.689M |
| Sept. 30, 2009 | -0.0185M |
| June 30, 2009 | 8.775M |
| March 31, 2009 | 0.00 |
| Dec. 31, 2008 | -1.543M |
| Sept. 30, 2008 | -0.2541M |
| June 30, 2008 | -0.1865M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
About Cash From Financing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More
SNSS Cash from Financing Quarterly Benchmarks
| Companies | |
|---|---|
| Biogen Idec | -238.42M |
| Curis | |
| Cell Therapeutics | 9.638M |
SNSS Cash from Financing Quarterly Rankings
| Overall |
86th percentile 1046 of 8006 |
| Sector |
81st percentile 129 of 686 in Healthcare |
| Industry |
75th percentile 60 of 248 in Biotechnology |
SNSS Cash from Financing Quarterly Range, Past 5 Years
| Minimum | -1.543M | Dec 2008 |
| Maximum | 38.80M | Jun 2010 |
| Average | 6.531M |
